Bruce & Co., Inc. Abb Vie Inc. Transaction History

Bruce & Co., Inc.

$240 Million
Q3 2024

A detailed history of Bruce & Co., Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bruce & Co., Inc. holds 146,500 shares of ABBV stock, worth $26.4 Million. This represents 12.04% of its overall portfolio holdings.

Number of Shares

146,500

Previous 161,500 9.29%

Holding current value

$26.4 Million

Previous $27.7 Million 4.44%

% of portfolio

12.04%

Previous 13.54%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $2.46 Million - $2.99 Million	-15,000 Reduced 9.29%	146,500 $28.9 Million
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $3.64 Million - $4.25 Million	23,500 Added 17.03%	161,500 $27.7 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $3.44 Million - $3.87 Million	-25,000 Reduced 15.34%	138,000 $21.4 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $3.84 Million - $4.45 Million	-28,743 Reduced 14.99%	163,000 $24.3 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.56 Million - $1.79 Million	-10,757 Reduced 5.31%	191,743 $30.6 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $2.9 Million - $3.48 Million	-21,000 Reduced 9.4%	202,500 $32.7 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $2.75 Million - $3.5 Million	-20,000 Reduced 8.21%	223,500 $34.2 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $7.92 Million - $9.83 Million	-60,000 Reduced 19.77%	243,500 $39.5 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $6.88 Million - $7.81 Million	-64,626 Reduced 17.56%	303,500 $32.7 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $4.09 Million - $4.5 Million	40,000 Added 12.19%	368,126 $39.8 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $448,892 - $606,052	5,577 Added 1.73%	328,126 $35.2 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $4.75 Million - $6.36 Million	64,749 Added 25.12%	322,549 $31.7 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $188,940 - $227,160	3,000 Added 1.18%	257,800 $19.5 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $1.12 Million - $1.44 Million	-17,115 Reduced 6.29%	254,800 $18.5 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $3.59 Million - $4.81 Million	39,000 Added 16.74%	271,915 $25.7 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $16.3 Million - $20.8 Million	232,915	232,915 $20.7 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.

Account